Bumper Offer - Urjas oil Just @ Rs. 1
AZULIX MV 2/0.3MG TABLET is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when AZULIX MV 2/0.3MG TABLET is used -
Moderate
Common
Unknown
Is the use of AZULIX MV 2/0.3MG TABLET safe for pregnant women?
Azulix MV can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Azulix MV right away. Take your doctor's advice before taking it again.
Is the use of AZULIX MV 2/0.3MG TABLET safe during breastfeeding?
Azulix MV is safe for breastfeeding women.
What is the effect of AZULIX MV 2/0.3MG TABLET on the Kidneys?
There may be some adverse effects on kidney after taking Azulix MV. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of AZULIX MV 2/0.3MG TABLET on the Liver?
Azulix MV can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of AZULIX MV 2/0.3MG TABLET on the Heart?
You may experience side effects on your heart after taking Azulix MV. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
AZULIX MV 2/0.3MG TABLET should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Unknown
If you are suffering from any of the following diseases, you should not take AZULIX MV 2/0.3MG TABLET unless your doctor advises you to do so -
Is this AZULIX MV 2/0.3MG TABLET habit forming or addictive?
AZULIX MV 2/0.3MG TABLET does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking AZULIX MV 2/0.3MG TABLET as it does not make you drowsy.
Is it safe?
Yes, but take AZULIX MV 2/0.3MG TABLET only as per medical advice.
Is it able to treat mental disorders?
No, the use of AZULIX MV 2/0.3MG TABLET in mental disorders is not effective.
Interaction between Food and AZULIX MV 2/0.3MG TABLET
Taking AZULIX MV 2/0.3MG TABLET with food is safe.
Interaction between Alcohol and AZULIX MV 2/0.3MG TABLET
Consuming AZULIX MV 2/0.3MG TABLET with alcohol can have many serious effects on your body.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 277
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158